NAD + is essential for redox reactions in energy metabolism and necessary for DNA repair and epigenetic modification. Humans require sufficient amounts of dietary niacin (nicotinic acid, nicotinamide, and nicotinamide riboside) for adequate NAD + synthesis. In contrast, mice easily generate sufficient NAD + solely from tryptophan through the kynurenine pathway. We show that transgenic mice with inducible expression of human alpha-amino-beta-carboxymuconate-semialdehyde decarboxylase (ACMSD) become niacin dependent similar to humans when ACMSD expression is high. On niacin-free diets, these acquired niacin dependency (ANDY) mice developed reversible, mild-to-severe NAD + deficiency, depending on the nutrient composition of the diet. NAD deficiency in mice contributed to behavioral and health changes that are reminiscent of human niacin deficiency. This study shows that ACMSD is a key regulator of mammalian dietary niacin requirements and NAD + metabolism and that the ANDY mouse represents a versatile platform for investigating pathologies linked to low NAD + levels in aging and neurodegenerative diseases.
Correspondence
In Brief Palzer et al. show that ACMSD overexpression renders mice dependent on dietary niacin in a manner similar to that of humans. On niacin-free diets, such mice become NAD + deficient. These mice can serve as a model for a range of human diseases such as aging and metabolic diseases that are associated with NAD + deficiency.
INTRODUCTION
Humans depend on B3 vitamins (nicotinic acid and nicotinamide), nicotinamide riboside, and tryptophan as dietary precursors for nicotinamide adenine dinucleotide (NAD + ) synthesis (Kirkland and Meyer-Ficca, 2018) . NAD + levels in whole blood can be measured to assess adequate dietary niacin intake (Fu et al., 1989; Jacobson et al., 1999; Tang et al., 2008) . NAD + levels vary significantly between individuals, and up to 15%-20% of the general population and 26% of elderly people may be niacin deficient, even in countries with niacin-fortification programs (Jacobson, 1993; Paulionis et al., 2005) . Such NAD + deficiency is often not clinically recognized or understood, but potentially highly prevalent and therefore a current research focus. Particularly aging-associated metabolic changes are linked to low NAD + levels (Imai, 2009 (Imai, , 2011 Imai and Guarente, 2014; Rehan et al., 2014) . NAD + and the reduced form NADH are coenzymes for redox reactions in metabolic processes such as the Krebs cycle, glycolysis, fatty acid oxidation, gluconeogenesis, and lipid and steroid synthesis. NAD + is also a co-substrate for sirtuins, which are epigenetic regulators, and ADP-ribose transferases. Sirtuins are class III NAD + -dependent histone deacetylases that regulate metabolic function, longevity, and aging (Imai and Guarente, 2016; O'Callaghan and Vassilopoulos, 2017) . Availability and redox status of NAD + are emerging as major factors in the development of disorders, including metabolic dysfunction linked to aging-related pathophysiology of the circadian rhythm, DNA repair, and cancer (Asher and Sassone-Corsi, 2015; Belden and Dunlap, 2008; Imai, 2010) . Variations in NAD + levels may therefore link the metabolic status of a cell to its epigenetic regulatory machinery. The ''NAD World'' describes this concept (Imai, 2009 (Imai, , 2010 (Imai, , 2016 Imai and Guarente, 2016) .
Modeling NAD + deficiency in rodents has been problematic because they efficiently convert tryptophan to NAD + via the kynurenine pathway ( Figure 1 ) and do not seem to depend as much on dietary niacin as a precursor for NAD + synthesis as humans. Humans need $60-70 mg of tryptophan to produce the equivalent of the amount of NAD + produced from 1 mg of niacin, if consuming an experimental diet that is tryptophan rich and niacin-free (Fukuwatari et al., 2004; Horwitt et al., 1981) . With limited dietary tryptophan, this conversion rate is even lower (Fu et al., 1989) . This relatively inefficient tryptophan-to-NAD + conversion rate, when compared to the conversion rate in rodents, makes humans susceptible to developing NAD + deficiency on niacin-free and protein-poor diets. Several knockout mouse models have been generated to disrupt the kynurenine pathway, but these mice either did not become truly NAD + deficient due to enzyme redundancy or the disruptions caused the accumulation of toxic intermediates (Terakata et al., 2012 (Terakata et al., , 2013 . Considering alternative strategies, we hypothesized that the differences in rodent and human niacin re- quirements may be caused by the different efficiency of a key enzymatic step in the de novo NAD + synthesis from tryptophan in the kynurenine pathway. In this step, the intermediate tryptophan metabolite alpha-amino-beta-carboxy-muconatesemialdehyde (ACMS) is either decarboxylated by the enzyme ACMS decarboxylase (ACMSD) to alpha-amino-muconate-semialdehyde (AMS) or left to undergo spontaneous cyclization to form quinolinic acid. Quinolinic acid then serves as a precursor for NAD + synthesis, whereas AMS spontaneously forms picolinic acid, which is ultimately metabolized to acetyl coenzyme A (acetyl-CoA). The efficiency of NAD + synthesis from tryptophan should therefore hinge on the extent of ACMS accumulation, which is regulated by ACMSD. Low ACMSD activity should permit efficient NAD + synthesis from tryptophan, while high ACMSD activity is expected to prevent efficient tryptophan-to-NAD + conversion. The formation of quinolinate and NAD + is impaired if there is high activity of ACMSD, and this appears to be a main source of variation between species in the efficiency of the conversion of tryptophan to NAD + (Ikeda et al., 1965) If ACMSD is the gatekeeper that shunts tryptophan to either NAD + or acetyl-CoA synthesis, then high ACMSD activity should result in the dependence of an individual on dietary niacin as a source of NAD + , which could be the case in niacin-dependent species such as humans. We generated a transgenic mouse model with inducible human (h)ACMSD overexpression (acquired niacin deficiency, or ANDY, mouse) to test the hypothesis that elevated ACMSD activity renders rodents niacin dependent, which should result in NAD + deficiency on a niacin-free diet. The results show that ANDY mice with ACMSD overexpression depend on dietary niacin intake and that their NAD + levels are tunable by defined diets, ranging from mildly to severely deficient. Our findings suggest that ANDY mice are a powerful and versatile model for a range of investigations into the links between NAD + levels and aging-related diseases, DNA repair, metabolic disease, as well as for dietary research.
RESULTS

Generation of Mice with Inducible Overexpression of hACMSD
The ANDY mouse model permits doxycycline (DOX)-inducible expression of human ACMSD to allow for precise control of transgene expression levels ( Figure S1A ). ANDY mice were gener- Tables S1 and S2 ).
(C and D) Reduced blood NAD + in male ANDY mice after 3 weeks (C) and 12 weeks (D) on niacin-free diet (ND1) compared to controls without hACMSD overexpression or on niacin-replete feed (CD1, chow). Data on ANDY/DOX/ND1 and ANDY/DOX/ CD1 mice are from 4 and 3 independent experiments in (C) and (D), respectively. All dataata represent mean ± SEM. (E) Lower NAD + levels in ANDY mice after 10 weeks on ND1 in all tissues tested. NADP + levels were also lower, with significant differences only seen in blood, liver, and brain. Dots represent individual mice in (C)-(E): red dots are ANDY/Dox/ ND1, blue dots are ANDY/DOX/CD1. One-way ANOVA, Tukey's multiple comparison test. All data represent mean ± SD. **p < 0.01, ***p < 0.001. See also Figures S1, S2, and S3. ated using mouse embryonic stem cells harboring a single copy of the human ACMSD coding sequence under control of the tetracycline operator (TetO) in safe-haven chromatin downstream of the Col1a1 locus, along with a copy of M2 reverse tetracycline transactivator (M2rtTA) constitutively expressed from the ROSA26 locus. DOX in drinking water elicits robust, dose-dependent gene activation in vivo . The resulting ANDY mice (C57BL/6J-Gt[Rosa]26Sor tm1[rTTa * M2]Jae Col1a1 tm6[tetO-ACMSD]MMF ) showed normal fertility and development, were born in normal Mendelian ratios, and exhibited no discernible phenotype in the absence of DOX.
DOX Administration Induces Robust, Sustained hACMSD Overexpression
Administration of DOX induced hACMSD expression from the transgene within 48 hr ( Figure S1B ). As long as DOX was administered, expression was maintained, with 4 months being the longest time interval tested (Figure 2A ). In addition, transgene expression levels depended on hemi-or homozygosity of the hACMSD and M2rtTA transgenes. ACMSD amounts were highest in ANDY mice homozygous for both transgenes, while hemizygosity of either the hACMSD or M2rtTA alleles (or both) resulted in reduced levels ( Figure S2A ). All subsequent investigations used ANDY mice homozygous at both the hACMSD and M2rtTA loci.
Acquired Niacin Dependency in Mice with hACMSD Overexpression
To evaluate dietary niacin requirements for maintaining blood NAD + levels, male ANDY mice were kept on either a niacin-free diet (ND1) or the same diet supplemented with 30 mg/kg niacin (CD1), or regular chow. Combining these diets with DOX-induced transgene expression or water-only controls resulted in six different treatment groups (ANDY/DOX/ND1, ANDY/DOX/CD1, ANDY/DOX/chow, ANDY/water/ND1, ANDY/water/CD1, ANDY/ water/chow; Figure 2B ). Animals lacking the M2rtTA transactivator necessary for ACMSD expression on ND1 and CD1 diets provided additional controls. After 3 weeks on the experimental diets, blood NAD + contents were significantly decreased in hACMSDexpressing ANDY mice on a ND1 (ANDY/DOX/ND1) relative to ANDY animals on the niacin-replete diet CD1 (ANDY/DOX/CD1) ( Figure 2C ). Additional controls at the 4-month point showed that the decreased NAD + status depended on the combination of ND1 and hACMSD overexpression. NAD + levels in animals on a niacin-replete control diet (CD1) or regular chow or in animals that did not overexpress hACMSD due to the absence of DOX or the M2rtTA were not significantly affected ( Figure 2D ). Of note, NAD + values were significantly reduced in the blood and tissues of niacin-deficient ND1-fed animals that overexpress hACMSD (+DOX) compared to ND1-fed ANDY mice not overexpressing hACMSD (water, ÀDOX) ( Figures 2D and S2B ). NAD + phosphate (NADP + ) remained stable until 3 weeks on a niacin-deficient diet ( Figure S2C ), but mice on an ND1 diet ultimately became NADP + deficient as well ( Figure S2D ). In line with the reduced blood NAD + contents, NAD + was also reduced in liver, kidney, spleen, and brain of ANDY mice on ND1 diet ( Figure 2E ). NADP + values were also lower in these tissues, but differences were only significant in liver, blood, and brain, and not kidney and spleen. Blood NAD + values decreased similarly in both male and female ANDY mice on a niacin-deficient diet ( Figures S3A and S3B) .
The data indicate that in the absence of hACMSD overexpression, mice do not become NAD + deficient on an ND1, suggesting that rodents efficiently metabolize tryptophan to NAD + via the de novo pathway. In contrast, elevated expression of hACMSD in the ANDY mice resulted in a dependency on dietary niacin for the synthesis of NAD + . hACMSD overexpression alone did not cause NAD + deficiency in animals on the niacin-replete CD1 diet or regular chow. Results from ANDY mice and from controls lacking the M2rtTA allele provide evidence that neither M2rtTA expression nor DOX administration alone affect NAD + levels in the absence of the hACMSD transgene. These data support the hypothesis that elevated expression of hACMSD results in the dependency of animals on dietary niacin to maintain normal NAD + and NADP + levels.
NAD + /NADH and NADP + /NADPH Deficiency in ANDY Mice Is Reversible
To determine the kinetics of declining NAD + and NADP + levels and the reversibility of the observed NAD + deficiency, we moni-tored blood NAD + /NADH and NADP + /NADPH levels over time in ANDY/DOX/ND1 and ANDY/DOX/CD1 mice. Total blood NAD + and NADP + were both significantly lower after 6 weeks and after 16 weeks on ND1 ( Figures 3A and 3B ). ND1-fed animals were then put on the niacin-replete CD1 diet. Two weeks after switching NAD + -deficient mice to the niacin-replete CD1 diet, blood NAD + and NADP + values had recovered and became indistinguishable from animals continuously fed the CD1 diet for 18 weeks. Animals on the CD1 diet also had a mild but reproducible and significant decline in blood total NAD + and NADH during the 16-week course of the feeding trials, which may be due to a natural age-related decline in NAD + , similar to what has been described in humans (Braidy et al., 2011; Zhu et al., 2015) ( Figures S4A and S4B) , to adaptation to the diets, or to the development of the mice.
Declines in both nucleotide pools in ANDY/DOX/ND1 mice call into question whether the ratio between NAD + and NADP + or the total NAD + /NADH pool alone is the most sensitive indicator of niacin deficiency. In clinical use, the ratio has the important advantage of being independent of sample size. The decline in blood total NADP + was less pronounced than the concomitant lowering of total NAD + /NADH, but statistically significant. These data support the notion that blood NADP + levels are more tightly controlled and fluctuate less than NAD + levels (Fu et al., 1989) , and they may indicate that NAD + depletion in the ANDY/DOX/ ND1 groups was severe. In ANDY/DOX/ND1 mice, overall niacin indices were reduced to <50% of controls, which would be considered severe in humans ( Figures S2D and S2E) .
To determine the extent to which tryptophan-to-niacin conversion is decreased in the ANDY model, a second diet (ND2) was formulated with 20% casein (twice the tryptophan of ND1). A niacin-replete diet with matched casein content served as a second control (CD2) ( Table S2 ). Blood NAD + levels in ANDY/DOX animals on ND2 (ANDY/DOX/ND2) for 12 weeks were lower than NAD + levels in animals on either niacin-replete control diet (ANDY/DOX/CD2 and ANDY/DOX/CD1), but less reduced than in ANDY/DOX/ND1 ( Figure 3C ), which shows that ANDY/DOX mice are still able to convert a small proportion of tryptophan to NAD + .
In summary, the data indicate that the reduced blood NAD + / NADH and NADP + /NADPH levels in hACMSD-overexpressing mice lacking dietary niacin return to normal upon dietary niacin intake. The data also provide evidence that limiting de novo NAD + synthesis from dietary tryptophan via the kynurenine pathway further exacerbates the NAD + and NADP + deficiencies caused by dietary niacin restriction. Thus, diets with defined niacin and tryptophan content can be used to reduce blood NAD + in ANDY mice to defined levels, ranging from mild deficiency on the ND2 diet to severe deficiency on the ND1 diet.
hACMSD Overexpression Results in Elevated Acetyl-CoA Levels Hepatic acetyl-CoA levels were significantly increased in all animals with induced hACMSD expression, regardless of diet (ND1, CD1, or chow diet) ( Figure 4A ), suggesting that a significant portion of acetyl-CoA may have been generated by tryptophan metabolism, but much of the acetyl-CoA could also stem from sources other than tryptophan. ANDY/DOX mice receiving standard chow had the highest acetyl-CoA levels, which may be explained by the higher casein, and therefore tryptophan, content in chow (20% instead of 10% in the CD1 and ND1 diets; Table S2 ). On average, hACMSD overexpression caused a 50% increase in liver acetyl-CoA ( Figure 4B ).
Altered NAD + /NADH Ratio and Redox State in NAD + -Deficient ANDY Mice As a coenzyme, NAD + /NADH is involved in redox reactions in which NAD + is the oxidizing form and NADH is the reducing form. The total NAD + /NADH ratio is estimated to normally range from 3 to 10 in mammals (Lin and Guarente, 2003) , which is consistent with results obtained from ANDY/DOX/CD1 and ANDY/DOX/chow controls ( Figure 5A ). In hACMSD-overexpressing ANDY/DOX/ND1, the NAD + /NADH ratio was significantly reduced. The low ratio was due to low NAD + but not NADH levels, which remained normal ( Figure 5A ).
NAD + Deficiency Is Associated with Lower Pyruvate and Elevated Lactate Levels
A metabolomics approach to characterize standard liver metabolites in ANDY and control mice indicated a significantly altered pyruvate-to-lactate ratio in the ANDY mice. In the presence of normal levels of the oxidizing coenzyme NAD + , lactate dehydrogenase activity converts lactate to pyruvate ( Figure 5C ). We quantified the ratio of the two metabolites using comparative gas chromatography-mass spectrometry (GC-MS) analyses of livers from niacin-deficient ANDY/DOX/ND1 and niacin-replete ANDY/DOX/CD1 mice. Livers from niacin-deficient animals con-tained significantly less pyruvate than those from CD1-fed animals ( Figure 5D ). In addition, niacin-deficient mice had increased lactate levels compared to CD1 control animals. Taken together, the data indicate that NAD + deficiency and the associated shift in the hepatic NAD + /NADH redox status in ANDY/DOX/ND1 mice led to a change in the pyruvate-to-lactate balance.
NAD + -Deficient Mice Lose Weight and Become
Lethargic ANDY/DOX/ND1 mice invariably lost weight during the course of the 14-week feeding trials ( Figure 6A ). This effect was more pronounced in males than in females ( Figure S3C ), which was surprising because females experienced a similar degree of total NAD + deficiency ( Figures S3A and S3B) . In contrast to the niacindeficient group, mice fed CD1 or regular chow gained between 10% and 25% of their starting body weight during the same time interval. CD1-fed mice (ANDY/DOX/CD1 and ANDY/water/ CD1) and ANDY/water/ND1 showed a tendency to become obese, likely due to the proportionally higher carbohydrate content of CD1 and ND1 diets compared to normal chow (Figures 6A and 6B). As early as 3 weeks into the feeding trial, body weights differed significantly between ANDY/DOX/ND1 and ANDY/DOX/ CD1 mice ( Figure 6A , *).
Mice on chow had growth curves typical of C57BL/6J mice (see C57BL/6J growth chart at https://www.jax.org/jaxmice-and-services/strain-data-sheet-pages/body-weight-chart-000664) and body weights consistent with animal age. Niacindeficient ANDY/DOX/ND1 was the only group with a downward trajectory of body weight development. Liver tissue from (Tables S3 and S4 ).
(C) Blood NAD + levels of male ANDY/DOX mice depended on the niacin and protein content in the diets that the animals received for 12 weeks (Tables S1 and S2 ANDY/DOX/CD1 mice exhibited histological changes consistent with obesity (fatty liver), while the livers of NAD + -deficient mice ANDY/DOX/ND1 were devoid of fat deposits ( Figure 6D ). MRI analyses of the body composition of ANDY/DOX mice at the end of the feeding trial on ND1, CD1, and chow diets showed a loss of body fat and a minor variation in lean body mass in NAD + -deficient animals, while mice on CD1 and chow gained body fat and lean mass ( Figure 6C ). Of note, all groups started the feeding trial with animals of comparable body composition and age distribution. At the termination of each trial, niacin-deficient ANDY/DOX/ND1 mice had accumulated less white adipose tissue (WAT; average epididymal fat pad weight) than ANDY/ DOX/CD1 or ANDY/DOX/chow mice ( Figure 6E ). WAT weight did not differ significantly between CD1 and chow control groups despite the fact that CD1 mice tended to become obese. ANDY/ water/ND1 mice without hACMSD transgene expression had WAT similar to CD1 mice. We concluded that hACMSD transgene expression and the resulting NAD + deficiency in ANDY/ DOX/ND1 mice may cause an inability to accumulate body fat. In addition, ANDY/DOX/ND1 mice had the smallest amounts of brown interscapular brown adipose tissue (BAT), together with mice on chow ( Figure 6F ). ANDY/DOX/CD1 mice had approximately three times larger BAT pads than ANDY/DOX/mice on ND1 or chow. BAT amounts in ANDY/water/ND1 (not overexpressing hACMSD) were comparable to CD1 mice and were 2.5-fold higher than ANDY/DOX/ND1 with transgene expression, again indicating that a lack of niacin in the diet alone did not significantly affect fat metabolism unless the mice simultaneously overexpressed hACMSD. Changes in calorie intake could be ruled out as a cause for the body weight changes between feeding groups over time. Daily calorie intake averaged $12 kcal/day ( Figure S3D ). Compared to chow (32%), ND1 and CD1 are relatively protein-poor (10%) and carbohydraterich diets (73% versus 54% in chow) with a similar fat content (16.8% versus 14% in chow). Food intake only decreased as mice became severely niacin deficient ( Figure S3E ), presumably secondary to behavioral changes. Varying degrees of anorexia are common for micronutrient deficiencies in rodents, which may be a protective mechanism against a more rapid metabolic decline with increased feeding on deficient diets. Feed efficiency in ND1-and CD1-fed animals was initially similar but dropped to negative values in ANDY/DOX/ND1, when animals had become NAD deficient after several weeks on the ND1 diet ( Figure S3F ). In line with the neurological symptoms (lethargy, apathy, and depression) seen in NAD + -deficient humans (Kirkland and Meyer-Ficca, 2018) , NAD + -deficient mice became lethargic and lacked activity. Compared to ANDY/DOX/CD1 mice, NAD + -deficient ANDY/DOX/ND1 mice trended toward lower activity in an open field test, which measures the distance a mouse travels to avoid being out in the open ( Figure 7A ). Compared to control animals, NAD + deficient mice showed reduced voluntary ambulatory activity ( Figure 7B ).
DISCUSSION
The results of this study support the hypotheses that increased ACMSD activity within the kynurenine pathway causes dependency on dietary niacin intake in a murine gain-of-function model and that ACMSD activity is a source of variation between species and individuals in the efficiency of conversion of tryptophan to niacin (Ikeda et al., 1965) .
The finding that ANDY mice can be rendered NAD + deficient to model human NAD + deficiency is of interest because NAD + is both an essential coenzyme for energy metabolism and a cosubstrate for NAD + -consuming enzymes mediating posttranslational protein modifications, such as sirtuins and ADP-ribose transferases (Imai and Guarente, 2014) . Due to these varied functions, cellular NAD + may link nutritional status and metabolic processes with the activity of epigenetic modulators. In addition, NAD + -dependent enzymes are involved in various human diseases (e.g., cancer, neurodegeneration, multiple sclerosis, Alzheimer disease, Huntington disease) and in aging and longevity. This makes NAD + metabolism an attractive target for drug discovery (Yoshino et al., 2018) . The experimental evidence obtained from ANDY mice highlights ACMSD as a master regulator at the intersection of acetyl-CoA and NAD + metabolism from tryptophan in the kynurenine pathway. Expression of the hACMSD transgene in ANDY mice increased hepatic acetyl-CoA levels by 50%. This suggests that although several different metabolic pathways form acetyl-CoA, the conversion from tryptophan may provide a significant portion of hepatic acetyl-CoA when hACMSD activity is high. Alternatively, low NAD + and NADP + availability may reduce the flux of metabolic pathways that consume acetyl-CoA, which could indirectly cause acetyl-CoA accumulation. The exact mechanisms causing the observed acetyl-CoA increase remain to be determined. These results are consistent with the hypothesis that ACMSD is a key enzyme that regulates the alternative processing of tryptophan to either NAD + or acetyl-CoA, and overexpression of ACMSD results in reduced NAD + levels when niacin intake is low.
Elevated hACMSD expression alone did not change NAD + levels, except in animals fed the niacin-free ND1 diet, but not in CD1-or chow-fed controls (Figure 2 ). In addition, there was no discernible phenotype of hACMSD expression itself in animals that were NAD + replete. Due to the absence of well-standardized methods for picolinate and quinolinate quantification, those intermediates were not measured. If elevated hACMSD expression altered picolinate or quinolinate production, then it did not result in an outward phenotype in the control animals. Picolinate, unlike quinolinate, has not been clearly identified as neurotoxic, but instead may have a physiological role in maintaining the balance between neurotoxic and neuroprotective kynurenine pathway metabolites (Grant et al., 2009) . No toxic effects of hACMSD overexpression or of DOX intake were seen in control animals not fed a niacindeficient diet, even with higher tryptophan uptake in animals on chow with its higher protein content.
The endogenous modulation of ACMSD activity can change hepatic NAD + levels (Shin et al., 1999) . Glucocorticoids and high-protein diets naturally upregulate ACMSD enzyme activity in wild-type rodents, and polyunsaturated fatty acids and a low-protein diet downregulate it (Egashira et al., 2004; Fukuoka et al., 2002) . ACMSD activity appears to be controlled at the transcriptional level. Peroxisome proliferator-activated receptor alpha (PPARa) negatively regulates transcription of nuclear factor 4 alpha, which normally maintains ACMSD expression (Shin et al., 2006) . Peroxisome proliferators thus increase hepatic NAD + by inhibiting ACMSD expression. In the ANDY mouse, DOX induces hACMSD overexpression independent of endogenous regulators. Increased hACMSD levels result in the opposite effect, which is decreased NAD + formation from tryptophan. Findings of the present study are therefore consistent with studies of endogenous ACMSD activity regulation. It has been shown that tryptophan and total nitrogen intake in mice increase ACMSD activity to form mostly acetyl-CoA. Mice eating 40%-70% protein had extremely high ACMSD activity, and tryptophan-to-nicotinamide conversion was extremely low (Shibata, 2018) . The ANDY mouse may mimic a situation of a high-protein diet, perhaps exacerbated by high carbohydrate intake, but in the absence of niacin intake. The resulting tryptophan-to-nicotinamide conversion is therefore low.
The ANDY mouse should enable future investigations into the pathophysiology of NAD + deficiency because it is a tractable small rodent model. Rats can temporarily become niacin deficient when kept on a gelatin/casein-based diet low in total protein (strongly limiting tryptophan intake) and free of niacin from weaning age on. The importance of niacin for genomic stability and for efficient DNA repair upon exposure to alkylating cytotoxic agents was demonstrated in such a model (Boyonoski et al., 1999; Kirkland, 2012; Rawling et al., 1994; Spronck and Kirkland, 2002) . The NAD + depletion observed in niacin-deficient rats led to genomic instability in part because NAD + is the substrate for poly(ADP-ribose) polymerases PARP1 and PARP2, which are involved in DNA strand break repair and epigenetic chromatin regulation. Dietary niacin deficiency in young rats also reduced levels of cyclic ADP-ribose formed from NAD + by CD38 and consequently altered learning (Young et al., 2007) . The transient NAD + deficiency achievable by such a gelatinbased diet in rats is limited to a short pre-pubertal period, which limits the versatility of such models and makes long-term studies (e.g., aging-related studies) difficult or impossible (Boyonoski et al., 1999; Rawling et al., 1994; Young et al., 2007) . Further-more, rats are less amenable to genetic modification than mice, and therefore there is a paucity of genetic tools available in rats. This further highlights the versatility of the ANDY mouse, which can be crossed to the plethora of widely available reporter and conditional alleles for the study of NAD + biology and metabolism.
Another advantage of increasing ACMSD activity to generate niacin dependency over a knockout approach, in which enzymes involved in the kynurenine pathway are deleted, is that it avoids the accumulation of toxic intermediates such as quinolinic acid. ACMSD activity depletes ACMS, the intermediate in the kynurenine pathway that is directed to NAD + synthesis and thereby prevents ACMS accumulation (Fukuoka et al., 2002; Fukuwatari et al., 2002 Fukuwatari et al., , 2004 . Very low ACMSD activity can cause the accumulation of ACMS and subsequently of quinolinic acid. Quinolinic acid is an excitotoxic metabolite that can cause or contribute to neurodegenerative processes such as epilepsy, Huntington disease (Beal et al., 1986; Feldblum et al., 1988) , Parkinson disease (Martí-Massó et al., 2013) , and vulnerability to suicidal behavior in humans (Brundin et al., 2016) . The need to prevent the accumulation of neurotoxic intermediates such as quinolinic acid likely caused evolutionary pressures favoring high ACMSD activity in humans, which in turn increases pellagra susceptibility. Quinolinic acid is metabolized by quinolinic acid ribosyltransferase (QPRT) to form nicotinic acid mononucleotide (NAMN). Transfer of an adenylate moiety to NAMN forms nicotinic acid adenine dinucleotide (NaAD). Amidation of the nicotinic acid moiety in NaAD to nicotinamide (Nam) finally forms NAD + . Besides ACMSD, QPRT therefore represents another rate-limiting step in the tryptophan-to-NAD + de novo synthesis pathway. Ablation of the Qprt gene in a mouse model resulted in quinolinic acid levels that were elevated >20-fold (Shibata, 2015; Terakata et al., 2012) . Several other genetic mouse models aimed at dis-rupting NAD + synthesis from the kynurenine pathway ( Figure 1 ) have been generated. Genetic deletion of the hepatic enzyme tryptophan 2,3-dioxygenase (TDO; Figure 1) , which forms N-formylkynurenine from tryptophan as the first and rate-limiting step of the entire kynurenine pathway, still allowed mice to maintain adequate NAD + levels, likely through the activity of indoleamine 2,3-dioxygenase (IDO) activity (Terakata et al., 2013) . The activity of IDO may have been able to compensate for the loss of TDO in the mutant mice, at least with respect to the maintenance of NAD + synthesis for energy metabolism. A genetic deletion of IDO affects the immune response in mice and a number of physiological responses (Baban et al., 2004) . A second IDO was discovered, IDO2 (Ball et al., 2007; Metz et al., 2007) , and TDO, IDO1, and IDO2 have common and distinct complex functions (Ball et al., 2014) . The important functions of these three enzymes, besides the initial metabolism of tryptophan in the kynurenine pathway, create complex phenotypes in mice with disruptions of these genes (Ball et al., 2014; Larkin et al., 2016; Too et al., 2016) . Similarly, the disruption of nicotinamide phosphoribosyltransferase (NAMPT), the enzyme that catalyzes the rate-limiting step in the NAD + salvage pathway, leads to toxic effects (Zabka et al., 2015) . In summary, the pioneering work of other laboratories showed either complex phenotypes or the accumulation of toxic metabolites in mice with gene deletions of enzymes involved in the kynurenine pathway. Moreover, the existing genetic knockout models, unlike the ANDY mouse, are not ''tunable,'' and germline gene deletions can alter development, making phenotype analysis in adult mice even more complex. It is likely that the poor efficiency of tryptophan conversion typical of humans is also related to high ACMSD expression, potentially as a neuroprotective mechanism, which would make the ANDY mouse a rodent model potentially applicable to human metabolism. ANDY mice showed progressive and reversible blood NAD + and NADP + deficiency over time, which was highly significant as early as 3 weeks after transgene induction on the ND1 niacin-deficient diet. ANDY mice lost weight, with concurrent alterations in behavior, which may at least in part be explained by the NAD + deficiency. NAD + is an important coenzyme for the conversion of lactate to pyruvate, and the limited availability of NAD + likely resulted in the observed altered lactate-to-pyruvate ratio. Because pyruvate is central to energy metabolism in the citrate cycle, reduced pyruvate levels may directly contribute to loss of body weight. In addition, disruption of NAD + redox homeostasis and concurrent mitochondrial dysfunction have been associated with metabolic disorders, as recently reviewed by Cantó et al. (2015) . NAD + and acetyl-CoA are both co-substrates for enzymes that modulate the epigenome, such as sirtuins, PARPs, and histone acetyl transferases and other protein acetyl transferases. Changing either NAD + levels or the relative availability of those two co-substrates may contribute to the altered epigenetic regulation of genes involved in the control of body weight and lipid metabolism, which is consistent with work by Cantó et al. (2009 ), Feige et al. (2008 , Krishnan et al. (2012) , and Verdin (2015) . The observed shift in the NAD + /NADH ratio raises the possibility that niacin-deficient mice have a lowered oxidizing capacity, while the stable NADH levels suggest that reducing equivalents are still available for the electron transport apparatus with similar efficiency to the niacin-replete state. In conclusion, the inducible ANDY mouse is a rodent model of dietary niacin dependence comparable to the human situation, with the potential to create varying NAD + levels and NAD + deficiency through dietary means. Phenotypic characterization of NAD + -deficient mice revealed weight loss, reduced liver pyruvate content indicative of low energy metabolism, and behavior changes, all of which are consistent with reduced whole-body niacin status. This model should be able to advance research on a vast array of pathologies associated with low NAD + metabolism, NAD + -dependent DNA repair processes, carcinogenesis, epigenetic mark formation, behavioral changes linked to niacin deficiency, and other areas, including metabolic disorders and aging.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: ethosulfate and 1 mg/ml alcohol dehydrogenase in 0.1 M bicine) or NADP + mix (0.2 M isocitrate, 1 M phosphate buffer pH 6.8, 10 mM thiazolyl blue, 0.2 M MgCl2, 100 mg/ml bovine serum albumine, 40 mM phenazine ethosulfate, 10 mg/ml isocitrate dehydrogenase) were added to each well to quantify NAD + or NADP + , respectively. The absorbance at 570 nm was measured immediately after addition of NAD mix and every 10 minutes for about 1 hour. The increase in absorbance over time was used to calculate concentrations. The niacin number of animals was calculated as a measure of niacin status using the following formula: (NAD + / [NAD + + NADP + ]) x 100% (Jacobson, 1993; Jacobson and Jacobson, 1997) , and then converted to relative niacin indices by dividing the niacin number of each sample by the average niacin numbers obtained in control animals on niacin replete diet (CD1).
